Drug intelligence / Profile preview

luprostiol

Development stage
Unknown
Lead developer
Norden Laboratories
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intramuscular
01

Overview

Luprostiol is a synthetic analogue of prostaglandin F2α, classified as a luteolytic agent. Its primary mechanism of action is to induce luteal regression in animals with an active corpus luteum, leading to subsequent follicle growth, estrus, and ovulation. It is used primarily in veterinary medicine for estrus control and termination of pregnancy in mares and cattle. Luprostiol acts by mimicking the effects of endogenous prostaglandin F2α on the corpus luteum, resulting in its breakdown (luteolysis). The drug is rapidly absorbed after intramuscular injection and metabolized quickly. It has been formulated as an injectable solution (typically 7.5 mg/mL) and has been available for veterinary use in Europe for several years[3][5][6][8].

Brand names
LuprostiolR
Other names
Luprostiolum
02

Targets

PTGFR (Prostaglandin F2 alpha receptor)

Beyond the preview

Go deeper on luprostiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on luprostiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call